Q3 2026 13F filing
Updated 6 days ago108 disclosed positions worth $5.7B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PRAXIS PRECISION MEDICINES I | $589.7M | 2.02M | 10.27% | — |
| 2 | A AMYLYX PHARMACEUTICALS INC | $307.7M | 10.57M | 5.36% | — |
| 3 | S SPYRE THERAPEUTICS INC | $292.1M | 3.28M | 5.09% | — |
| 4 | M MODERNA INC | $269.6M | 1.40M | 4.70% | — |
| 5 | C CELCUITY INC | $252.9M | 3.18M | 4.41% | — |
| 6 | R RHYTHM PHARMACEUTICALS INC | $241.1M | 2.53M | 4.20% | — |
| 7 | R ROIVANT SCIENCES LTD | $238.1M | 6.51M | 4.15% | — |
| 8 | R RELAY THERAPEUTICS INC | $229.8M | 12.73M | 4.00% | — |
| 9 | A ASCENDIS PHARMA A/S | $221.3M | 971.5K | 3.86% | — |
| 10 | T TRAVERE THERAPEUTICS INC | $208.6M | 3.54M | 3.63% | — |
| 11 | F FREENOME INC | $198.5M | 12.61M | 3.46% | — |
| 12 | E EDGEWISE THERAPEUTICS INC | $168M | 4.14M | 2.93% | — |
| 13 | I INHIBRX BIOSCIENCES INC | $129.3M | 1.29M | 2.25% | — |
| 14 | N NURIX THERAPEUTICS INC | $127.4M | 5.37M | 2.22% | — |
| 15 | ? N/A KARDIGAN INC | $121M | 8.20M | 2.11% | — |
| 16 | M MEIRAGTX HLDGS PLC | $118.7M | 10.79M | 2.07% | — |
| 17 | P PROTAGONIST THERAPEUTICS INC | $117.9M | 836.6K | 2.05% | — |
| 18 | I IMMATICS N.V | $98.7M | 11.25M | 1.72% | — |
| 19 | Z ZYMEWORKS INC | $93.9M | 3.55M | 1.64% | — |
| 20 | O ORUKA THERAPEUTICS INC | $89.3M | 1.07M | 1.56% | — |
| 21 | R REVOLUTION MEDICINES INC | $88.9M | 433.1K | 1.55% | — |
| 22 | S SOLID BIOSCIENCES INC | $86.1M | 11.91M | 1.50% | — |
| 23 | B BIOCRYST PHARMACEUTICALS INC | $85.8M | 10.30M | 1.50% | — |
| 24 | A AVALYN PHARMACEUTICALS INC | $76.2M | 2.68M | 1.33% | — |
| 25 | T TANGO THERAPEUTICS INC | $67.2M | 2.69M | 1.17% | — |
| 26 | W WATERS CORP | $59.3M | 135.0K | 1.03% | — |
| 27 | R REPLIGEN CORP | $52.4M | 272.5K | 0.91% | — |
| 28 | A ARTIVION INC | $48.2M | 2.11M | 0.84% | — |
| 29 | A ALTO NEUROSCIENCE INC | $45M | 1.76M | 0.78% | — |
| 30 | I OPUS GENETICS INC | $43.6M | 9.00M | 0.76% | — |
| 31 | S SELLAS LIFE SCIENCES GROUP I | $36.9M | 3.00M | 0.64% | — |
| 32 | G LAKEFRONT BIOTHERAPEUTICS NV | $36.8M | 1.24M | 0.64% | — |
| 33 | A ABBOTT LABORATORIES | $34.1M | 345.2K | 0.59% | — |
| 34 | ? N/A BLOSSOMHILL THERAPEUTICS INC | $33.8M | 1.81M | 0.59% | — |
| 35 | S SPDR SERIES TRUST | $31.5M | 200.0K | 0.55% | — |
| 36 | O ORCHESTRA BIOMED HLDGS INC | $31.3M | 5.04M | 0.55% | — |
| 37 | S SELLAS LIFE SCIENCES GROUP I | $30.8M | 2.50M | 0.54% | — |
| 38 | C CORVUS PHARMACEUTICALS INC | $28.9M | 2.51M | 0.50% | — |
| 39 | A ANTERIS TECHNOLOGIES GLOBAL | $26.6M | 3.43M | 0.46% | — |
| 40 | A ADLAI NORTYE GROUP LTD | $26.6M | 1.66M | 0.46% | — |
| 41 | M MINIMED GROUP INC | $25.7M | 1.32M | 0.45% | — |
| 42 | C CYTOMX THERAPEUTICS INC. | $25.2M | 9.27M | 0.44% | — |
| 43 | R RAPPORT THERAPEUTICS INC | $24.3M | 724.3K | 0.42% | — |
| 44 | S SEPTERNA INC | $22.2M | 567.5K | 0.39% | — |
| 45 | ? N/A X4 PHARMACEUTICALS INC | $21.3M | 7.35M | 0.37% | — |
| 46 | E ENLIVEN THERAPEUTICS INC | $21.2M | 462.5K | 0.37% | — |
| 47 | S SAB BIOTHERAPEUTICS INC | $21M | 6.63M | 0.37% | — |
| 48 | D DYNE THERAPEUTICS INC | $20.4M | 1.27M | 0.36% | — |
| 49 | E EVOLUS INC | $19.7M | 2.46M | 0.34% | — |
| 50 | Y YARROW BIOSCIENCE INC | $18.3M | 813.1K | 0.32% | — |